These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8069621)

  • 1. Influenza B virus neuraminidase can synthesize its own inhibitor.
    Burmeister WP; Henrissat B; Bosso C; Cusack S; Ruigrok RW
    Structure; 1993 Sep; 1(1):19-26. PubMed ID: 8069621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of influenza virus neuraminidase B/Lee/40 complexed with sialic acid and a dehydro analog at 1.8-A resolution: implications for the catalytic mechanism.
    Janakiraman MN; White CL; Laver WG; Air GM; Luo M
    Biochemistry; 1994 Jul; 33(27):8172-9. PubMed ID: 8031750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional structure of influenza A N9 neuraminidase and its complex with the inhibitor 2-deoxy 2,3-dehydro-N-acetyl neuraminic acid.
    Bossart-Whitaker P; Carson M; Babu YS; Smith CD; Laver WG; Air GM
    J Mol Biol; 1993 Aug; 232(4):1069-83. PubMed ID: 8371267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid.
    Burmeister WP; Ruigrok RW; Cusack S
    EMBO J; 1992 Jan; 11(1):49-56. PubMed ID: 1740114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel aromatic inhibitors of influenza virus neuraminidase make selective interactions with conserved residues and water molecules in the active site.
    Finley JB; Atigadda VR; Duarte F; Zhao JJ; Brouillette WJ; Air GM; Luo M
    J Mol Biol; 1999 Nov; 293(5):1107-19. PubMed ID: 10547289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B.
    Taylor NR; Cleasby A; Singh O; Skarzynski T; Wonacott AJ; Smith PW; Sollis SL; Howes PD; Cherry PC; Bethell R; Colman P; Varghese J
    J Med Chem; 1998 Mar; 41(6):798-807. PubMed ID: 9526556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of inhibitor binding in influenza virus neuraminidase.
    Smith BJ; Colman PM; Von Itzstein M; Danylec B; Varghese JN
    Protein Sci; 2001 Apr; 10(4):689-96. PubMed ID: 11274459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structures of Salmonella typhimurium LT2 neuraminidase and its complexes with three inhibitors at high resolution.
    Crennell SJ; Garman EF; Philippon C; Vasella A; Laver WG; Vimr ER; Taylor GL
    J Mol Biol; 1996 Jun; 259(2):264-80. PubMed ID: 8656428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular modeling studies on ligand binding to sialidase from influenza virus and the mechanism of catalysis.
    Taylor NR; von Itzstein M
    J Med Chem; 1994 Mar; 37(5):616-24. PubMed ID: 8126701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structures of aromatic inhibitors of influenza virus neuraminidase.
    Jedrzejas MJ; Singh S; Brouillette WJ; Laver WG; Air GM; Luo M
    Biochemistry; 1995 Mar; 34(10):3144-51. PubMed ID: 7880809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor.
    Varghese JN; McKimm-Breschkin JL; Caldwell JB; Kortt AA; Colman PM
    Proteins; 1992 Nov; 14(3):327-32. PubMed ID: 1438172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase.
    Varghese JN; Epa VC; Colman PM
    Protein Sci; 1995 Jun; 4(6):1081-7. PubMed ID: 7549872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of the human cytosolic sialidase Neu2. Evidence for the dynamic nature of substrate recognition.
    Chavas LM; Tringali C; Fusi P; Venerando B; Tettamanti G; Kato R; Monti E; Wakatsuki S
    J Biol Chem; 2005 Jan; 280(1):469-75. PubMed ID: 15501818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of a bacterial sialidase (from Salmonella typhimurium LT2) shows the same fold as an influenza virus neuraminidase.
    Crennell SJ; Garman EF; Laver WG; Vimr ER; Taylor GL
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):9852-6. PubMed ID: 8234325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The high resolution structures of free and inhibitor-bound Trypanosoma rangeli sialidase and its comparison with T. cruzi trans-sialidase.
    Amaya MF; Buschiazzo A; Nguyen T; Alzari PM
    J Mol Biol; 2003 Jan; 325(4):773-84. PubMed ID: 12507479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based inhibitors of influenza virus sialidase. A benzoic acid lead with novel interaction.
    Singh S; Jedrzejas MJ; Air GM; Luo M; Laver WG; Brouillette WJ
    J Med Chem; 1995 Aug; 38(17):3217-25. PubMed ID: 7650674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A benzoic acid inhibitor induces a novel conformational change in the active site of Influenza B virus neuraminidase.
    Lommer BS; Ali SM; Bajpai SN; Brouillette WJ; Air GM; Luo M
    Acta Crystallogr D Biol Crystallogr; 2004 Jun; 60(Pt 6):1017-23. PubMed ID: 15159560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A sialic acid-derived phosphonate analog inhibits different strains of influenza virus neuraminidase with different efficiencies.
    White CL; Janakiraman MN; Laver WG; Philippon C; Vasella A; Air GM; Luo M
    J Mol Biol; 1995 Feb; 245(5):623-34. PubMed ID: 7844831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights from modeling the 3D structure of H5N1 influenza virus neuraminidase and its binding interactions with ligands.
    Wei DQ; Du QS; Sun H; Chou KC
    Biochem Biophys Res Commun; 2006 Jun; 344(3):1048-55. PubMed ID: 16647045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fusing mumps virus variant selected from a nonfusing parent with the neuraminidase inhibitor 2-deoxy-2,3-dehydro-N-acetylneuraminic acid.
    Waxham MN; Wolinsky JS
    Virology; 1986 Jun; 151(2):286-95. PubMed ID: 3754671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.